168 related articles for article (PubMed ID: 21890265)
1. Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue.
Lysaght J; van der Stok EP; Allott EH; Casey R; Donohoe CL; Howard JM; McGarrigle SA; Ravi N; Reynolds JV; Pidgeon GP
Cancer Lett; 2011 Dec; 312(1):62-72. PubMed ID: 21890265
[TBL] [Abstract][Full Text] [Related]
2. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
3. MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation.
Allott EH; Lysaght J; Cathcart MC; Donohoe CL; Cummins R; McGarrigle SA; Kay E; Reynolds JV; Pidgeon GP
Mol Carcinog; 2013 Feb; 52(2):144-54. PubMed ID: 22121096
[TBL] [Abstract][Full Text] [Related]
4. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans.
Garaulet M; Hernandez-Morante JJ; Lujan J; Tebar FJ; Zamora S
Int J Obes (Lond); 2006 Jun; 30(6):899-905. PubMed ID: 16446749
[TBL] [Abstract][Full Text] [Related]
5. Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients.
Zeyda M; Huber J; Prager G; Stulnig TM
Obesity (Silver Spring); 2011 Apr; 19(4):743-8. PubMed ID: 20508627
[TBL] [Abstract][Full Text] [Related]
6. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
Paulsen SK; Pedersen SB; Fisker S; Richelsen B
Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia induced VEGF synthesis in visceral adipose depots of obese diabetic patients.
Fusaru AM; Pisoschi CG; Bold A; Taisescu C; Stănescu R; Hîncu M; Crăiţoiu S; Baniţă IM
Rom J Morphol Embryol; 2012; 53(4):903-9. PubMed ID: 23303012
[TBL] [Abstract][Full Text] [Related]
8. Visceral obesity, metabolic syndrome, insulin resistance and cancer.
Doyle SL; Donohoe CL; Lysaght J; Reynolds JV
Proc Nutr Soc; 2012 Feb; 71(1):181-9. PubMed ID: 22051112
[TBL] [Abstract][Full Text] [Related]
9. Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obese.
Bennetzen MF; Nielsen TS; Paulsen SK; Bendix J; Fisker S; Jessen N; Lund S; Richelsen B; Pedersen SB
Eur J Clin Invest; 2010 Feb; 40(2):121-6. PubMed ID: 20039929
[TBL] [Abstract][Full Text] [Related]
10. T lymphocyte activation in visceral adipose tissue of patients with oesophageal adenocarcinoma.
Lysaght J; Allott EH; Donohoe CL; Howard JM; Pidgeon GP; Reynolds JV
Br J Surg; 2011 Jul; 98(7):964-74. PubMed ID: 21520028
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes in fatty acids from different adipose depots in rat and their association with adiposity and insulin.
de Heredia FP; Larque E; Portillo MP; Canteras M; Zamora S; Garaulet M
Nutrition; 2008 Oct; 24(10):1013-22. PubMed ID: 18562171
[TBL] [Abstract][Full Text] [Related]
12. Visceral adiposity in gastrointestinal and hepatic carcinogenesis.
Vongsuvanh R; George J; Qiao L; van der Poorten D
Cancer Lett; 2013 Mar; 330(1):1-10. PubMed ID: 23201597
[TBL] [Abstract][Full Text] [Related]
13. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.
Viljanen AP; Lautamäki R; Järvisalo M; Parkkola R; Huupponen R; Lehtimäki T; Rönnemaa T; Raitakari OT; Iozzo P; Nuutila P
Ann Med; 2009; 41(2):152-60. PubMed ID: 18855190
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity.
Ngo DT; Farb MG; Kikuchi R; Karki S; Tiwari S; Bigornia SJ; Bates DO; LaValley MP; Hamburg NM; Vita JA; Hess DT; Walsh K; Gokce N
Circulation; 2014 Sep; 130(13):1072-80. PubMed ID: 25116954
[TBL] [Abstract][Full Text] [Related]
15. Abdominal visceral adipose tissue predicts risk of colorectal adenoma in both sexes.
Nam SY; Kim BC; Han KS; Ryu KH; Park BJ; Kim HB; Nam BH
Clin Gastroenterol Hepatol; 2010 May; 8(5):443-50.e1-2. PubMed ID: 20144736
[TBL] [Abstract][Full Text] [Related]
16. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women.
Drolet R; Bélanger C; Fortier M; Huot C; Mailloux J; Légaré D; Tchernof A
Obesity (Silver Spring); 2009 Mar; 17(3):424-30. PubMed ID: 19219061
[TBL] [Abstract][Full Text] [Related]
17. Not all fat is equal: differential gene expression and potential therapeutic targets in subcutaneous adipose, visceral adipose, and endometrium of obese women with and without endometrial cancer.
Modesitt SC; Hsu JY; Chowbina SR; Lawrence RT; Hoehn KL
Int J Gynecol Cancer; 2012 Jun; 22(5):732-41. PubMed ID: 22635025
[TBL] [Abstract][Full Text] [Related]
18. Human visceral adipose tissue and the plasminogen activator inhibitor type 1.
Lindeman JH; Pijl H; Toet K; Eilers PH; van Ramshorst B; Buijs MM; van Bockel JH; Kooistra T
Int J Obes (Lond); 2007 Nov; 31(11):1671-9. PubMed ID: 17471294
[TBL] [Abstract][Full Text] [Related]
19. Obesity reduces the pro-angiogenic potential of adipose tissue stem cell-derived extracellular vesicles (EVs) by impairing miR-126 content: impact on clinical applications.
Togliatto G; Dentelli P; Gili M; Gallo S; Deregibus C; Biglieri E; Iavello A; Santini E; Rossi C; Solini A; Camussi G; Brizzi MF
Int J Obes (Lond); 2016 Jan; 40(1):102-11. PubMed ID: 26122028
[TBL] [Abstract][Full Text] [Related]
20. Characterization of stromal vascular fraction and adipose stem cells from subcutaneous, preperitoneal and visceral morbidly obese human adipose tissue depots.
Silva KR; Côrtes I; Liechocki S; Carneiro JR; Souza AA; Borojevic R; Maya-Monteiro CM; Baptista LS
PLoS One; 2017; 12(3):e0174115. PubMed ID: 28323901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
